Clinical trial
Retinal Imaging in Neurodegenerative Disease
NCT03233646
Study timeline
Study start (actual)2017-07-20Date precision: day
Registry last updated2026-02-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Mild Cognitive Impairmentunresolved
Parkinson's Diseaseunresolved
Multiple Sclerosisunresolved
Huntington Diseaseunresolved
Lewy Body Dementiaunresolved
Frontotemporal Dementiaunresolved
Amyotrophic Lateral Sclerosis (ALS)unresolved
APOE-4 Positiveunresolved
Traumatic Brain Injuryunresolved
Concussionunresolved
Post-Traumatic Stress Disorderunresolved
Down Syndromeunresolved
Neuro-Degenerative Diseaseunresolved
Normal Cognitionunresolved
Interventions
Sponsors & collaborators
Duke Universitylead sponsor
University of Edinburgh in Scotlandcollaborator
Tan Tock Seng Hospital in Singaporecollaborator
Queens University of Belfast United Kingdomcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03233646 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.